ada.enesco, Author at European Medical Journal - Page 7 of 66

Ultra-Processed Foods Threaten Global Human Health, Experts Warn

Ultra-processed foods harm health and raise chronic disease risk. Experts call for regulation, warning labels, and support for minimally processed foods.

Gut Microbiota Imbalance Linked to Rapid Global Rise in IBD

Global research finds that gut microbiota dysbiosis strongly correlates with rising inflammatory bowel disease rates worldwide.

Obesity and Comorbidities Drive GLP-1 Agonist Use in Hidradenitis Suppurativa

GLP-1 agonists are more often prescribed for hidradenitis suppurativa patients with obesity, diabetes, and other metabolic conditions.

Flu Rising Unusually Early This Season, Reports UKHSA

The latest UKHSA winter surveillance bulletin shows flu activity rising unusually early, while COVID-19 remains low and RSV begins to increase.

Inhaled Corticosteroids Protect Infants’ Lungs from Maternal Asthma

Maternal use of inhaled corticosteroids during pregnancy improves early lung function in infants born to asthmatic mothers. This intervention may reduce early respiratory risk.

Ultra-Processed Foods Linked to Prediabetes Risk in Youth

A study in young adults shows that ultra-processed foods increase the risk of prediabetes and insulin resistance. Limiting ultra-processed foods may help prevent type 2 diabetes.

Paracetamol in Pregnancy: What the Evidence Really Says About Autism and ADHD

Large umbrella review finds no clear link between maternal paracetamol use during pregnancy and autism or ADHD in children.

Better Sleep Linked to Lower Migraine Risk, Major UK Study Finds

A major UK study of 309,000 adults links better sleep quality to a lower risk of developing migraines, partly explained by healthier cholesterol levels.

Diabetes Diet Preference: Which Low-Energy Plan Suits You?

New study reveals how lifestyle, goals, and convenience shape diabetes patients’ diet choices, guiding better patient-centred advice.

Exploring Endolysin Therapy for Atopic Dermatitis Relief

While further large-scale trials are needed, this precision-based treatment represents a promising advance in managing atopic dermatitis.